banner-historie.jpg

Our history

The MEDICE success story began in Iserlohn in 1949. Today MEDICE is one of the leading SME healthcare companies in Germany and is also diversified internationally.


1949

Company foundation

Foundation of MEDICE in Iserlohn by Gustav Pütter, inventor of the Pütter bandage.

1953

Launch of Meditonsin®

Product launch of Meditonsin®, our natural cold remedy – since then proven a million times over in acute inflammation of the throat, nasal cavity and pharynx.

1977

Dr. med. S. Pütter joins the company

Dr. med. Sigurd Pütter, the 2nd generation of the family takes over management at MEDICE.

1989

Launch of nephrology drugs

Introduction of the successful ‘MEDICE nephrology’ range of drugs for renal patients.

2000

Launch of Medikinet®

Introduction of Medikinet® – medicinal product for multimodal therapy of ADHD.

2001

Dr. med. K. Pütter-Ammer joins

With Dr. med. Katja Pütter-Ammer, the 3rd generation of the family joins the company.

2003

Dr. med. Dr. oec. R. Ammer joins

Dr. med. Dr. oec. (Economics) Richard Ammer joins the company MEDICE as a further Managing Director.

2006

Acquisition of Rentschler

With the acquisition of Rentschler Arzneimittel, MEDICE completes further strategic expansion of its OTC business. Expansion of OTC products with successful brands like Dorithricin® for the treatment of sore throats and Tannacomp® for diarrhoea.

2007

Launch of Abseamed®

Launch of Abseamed® as the first biosimilar with the active pharmaceutical ingredient erythropoietin alfa (Epoetin) for the treatment of anaemia to be approved in the EU.

2011

Launch of Medikinet® Adult and Monofer®

Launch of Medikinet® adult, the first drug approved in Germany for the treatment of ADHD in adults. Launch of Monofer®, which allows a safe and high-dose infusion of iron as a single dose.

2012

E. Neyret joins

Eric Neyret joins MEDICE as new Managing Director for Finance, Controlling and Administration.

2012

Acquisition of Perenterol®

Acquisition of sales and distribution of Perenterol® against diarrhoea and for the prevention of travel diarrhoea.

2014

Dr. J. Kreimeyer joins

Dr. Jürgen Kreimeyer becomes the new Managing Director of MEDICE for Marketing & Sales and Medical Science (OTC).

2017

Launch of Attentin®

Launch of the first and only dexamfetamine finished medicinal product.

2019

Reconstruction of the MEDICE administration building

Completion of the new four-storey MEDICE administration building with 2,700 sqm of floor space.